These novel small molecules, called NV848, NV914, and NV930, demonstrated high readthrough activity by producing a full‐length, functional CFTR protein either from mutant CFTR cDNAs with UGA stop mutations as well as in a cell model of CF [28, 29], without impacting NTCs [10]. This evidence concerns the gene CFTR and cystic fibrosis.